@article{53e42557a481466ab0bcea8c97522318,
title = "Experience with COVID-19 convalescent plasma provides vital guidance to future pandemics",
author = "Jan Hartmann and Bloch, {Evan M.} and Thierry Burnouf",
note = "Funding Information: All authors are inaugural members of the AABB Passive Antibody Therapies Forum Advisory Group. JH is an employee of Haemonetics Corporation, a manufacturer of plasma collection devices; EMB reports personal fees and nonfinancial support from Terumo BCT, Grifols Diagnostics Solutions, and Abbott Laboratories outside of the submitted work; EMB is a member of the FDA Blood Products Advisory Committee. Any views or opinions that are expressed in this manuscript are that of the author's, based on his own scientific expertise and professional judgment; they do not necessarily represent the views of either the Blood Products Advisory Committee or the formal position of FDA and also do not bind or otherwise obligate or commit either Advisory Committee or the Agency to the views expressed. TB's laboratory at Taipei Medical University has received research grants from plasma industry suppliers (Asahi‐Kasei Medical; Merck‐Millipore), and TB has served on the scientific advisory board of Haemonetics Corporation.",
year = "2022",
doi = "10.1111/trf.16810",
language = "English",
volume = "62",
pages = "681--684",
journal = "Transfusion",
issn = "0041-1132",
publisher = "John Wiley and Sons Inc.",
number = "3",
}